Evolution of iGF-1 in children born small for gestational age and with growth retardation, treated by growth hormone adapted to IGF-1 levels after 1 year

Hormone Research in Paediatrics

Volumn 76, Issue 6, 2011, Pages 419-427

  Cabrol, S ^a   Perin, L ^a   Colle, M ^c   Coutant, R ^d   Jesuran Perelroizen M ^e   Le Bouc, Y ^a   Czernichow, P ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Center of Paediatric Endocrinology   (France)

^d Department of Paediatric Endocrinology ^*  (France)

^e Center of Paediatric Endocrinology   (France)

Author keywords

Growth hormone; Insulin like growth factor 1; Insulin like growth factor binding protein 3; Small for gestational age

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATREM;

ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; GROWTH RATE; GROWTH RETARDATION; HUMAN; LOADING DRUG DOSE; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SMALL FOR DATE INFANT;

ALGORITHMS; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG RESISTANCE; FEMALE; FETAL GROWTH RETARDATION; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS;

EID: 83755224728     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000334651     Document Type: Article

References (18)

1. De Zegher F, Albertsson-Wickland K, Wollmann HA, Chatelain P, Chaussain JL, Löfström A, Jonsson B, Rosenfeld RG: Growth hormone treatment of short children born small for gestational age: growth responses with continuous and discontinuous regimens over 6 years. J Clin Endocrinol Metab 2000; 85: 2816-2821. (Pubitemid 32269158)
2. van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A: Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 2003; 88: 3584-3590. (Pubitemid 37034499)
3. Ranke MB, Lindberg A, Cowell CT, Wikland KA, Reiter EO, Wilton P, Price DA, KIGS International Board: Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database). 2003.
4. Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group: Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study. J Clin Endocrinol Metab 2007; 92: 2480-2486. (Pubitemid 47037346)
5. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM, 2007 ISS Consensus Workshop Participants: Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008; 93: 4210-4217. (Pubitemid 352806728)
6. Usher R, McLean F: Intrauterine growth of live born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. Pediatrics 1969; 74: 901-910.
7. Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity and stages of puberty. Arch Dis Child 1976; 51: 170-179.
8. Sempé M, Pédron G, Roy-Pernot MP: Auxologie: Méthode et Séquences. Paris, Théraplix, 1979.
9. Lee PA, Chernausek SD, Hokken-Koelaga ACS, Czernichow P, for the International SGA Advisory Board: International small for gestational age advisory board consensus development conference statement: management of short children born small for gestational age. Pediatrics. 2003; 111: 1253-1261. (Pubitemid 36682257)
10. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A: Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 2007; 92: 804-810. (Pubitemid 46465644)
11. Rapaport R, Saenger P, Wajnrajch MP, Pfizer SGA Collaborative Study Group: Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an openlabel, multicenter trial in the United States. J Pediatr Endocrinol Metab 2008; 21: 411-422. (Pubitemid 351894989)
12. www.ema.europa.eu/pdfs/human/referral/ genotropin/347703en. 2003.
13. Brabant G, von zur Mühlen A, Wüster C, Ranke MB, Kratzsch J, Kiess W, Ketelslegers JM, Wilhelmsen L, Hulthén L, Saller B, Mattsson A, Wilde J, Schemer R, Kann P, German KIMS Board: Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm Res 2003; 60: 53-60. (Pubitemid 36928670)
14. Park P, Cohen P: The role of insulin-like growth factor I monitoring in growth hormone- treated children. Horm Res 2004; 62(suppl 1): 59-65. (Pubitemid 40529152)
15. Dahlgren J, Wikland KA, Swedish Study Group for Growth Hormone Treatment: Final height in short children born small for gestational age treated with growth hormone. Pediatr Res 2005; 57: 216-222. (Pubitemid 40165598)
16. Gelander L, Blum WF, Larsson L, Rosberg S, Albertsson-Wikland K: Monthly easurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study. Pediatr Res 1999; 45: 377-383. (Pubitemid 29157771)
17. Milani D, Carmichael JD, Welkowitz J, Ferris S, Reitz RE, Danoff A, Kleinberg DL: Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development. J Clin Endocrinol Metab 2004; 89: 2271-2274. (Pubitemid 38619863)
18. Frystyk J, Freda P, Clemmons DR: The current status of IGF-I assays - a 2009 update. Growth Horm IGF Res 2010; 20: 8-18.